Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer initiates phase II study of PF-06700841 topical cream for atopic dermatitis

June 6, 2019

GlaxoSmithKline initiates phase I study of HBV therapeutic vaccines

June 6, 2019

FDA clears IND for NantKwest's CD19.t-haNK cell therapy

June 6, 2019

IND cleared for phase II trial of zilucoplan in immune-mediated necrotizing myopathy

June 5, 2019

Phase II trial of risuteganib for dry AMD meets primary endpoint

June 5, 2019

Hemogenyx reports in vivo data on CDX bispecific antibody for AML

June 5, 2019

Aslan reports final results from single-ascending-dose study of ASLAN-004

June 5, 2019

Anxiolytic effect for JNJ-61393215 seen in humans

June 5, 2019

AZP-3404 restores glucose homeostasis in leptin-deficient obese mice

June 5, 2019

FDA accepts Prevail's IND for phase I/II study of PR-001 for Parkinson's disease with GBA1 mutation

June 5, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...